AGILENT TECHNOLOGIES ÖSTERREICH GMBH - Austria 

This institution has been merged with: AGILENT TECHNOLOGIES FRANCE.

Ranking results:

Past rankings:

2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:900-1000
Total Number of Projects:69
Total Project Funding:800-900
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2007
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2012 0 12.000.000 631.579 1
2011 0 29.996.664 21.602 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
CELLZOME2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE2
UNIVERSITY COLLEGE LONDON2
ACADEMISCH ZIEKENHUIS GRONINGEN1
ARIADNE DIAGNOSTICS LLC1
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION1
BIOPRODICT BV1
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
DEUTSCHES ZENTRUM FUER NEURODEGENERATIVE ERKRANKUNGEN EV1
DIAGENODE1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EUROPEAN RESEARCH AND PROJECT OFFICE1
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE1
FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA1
FUNDACIO PRIVADA PARC CIENTIFIC DE BARCELONA1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
GENOMATIX SOFTWARE1
GENOME RESEARCH1
HALO GENOMICS AB1
ISLENSK ERFDAGREINING EHF1
ISTITUTO EUROPEO DI ONCOLOGIA1
KLINIKUM DER UNIVERSITAET ZU KOELN1
LEIDEN UNIVERSITY MEDICAL CENTER1
LUNDS UNIVERSITET1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
NOVARTIS FORSCHUNGSSTIFTUNG ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH1
OXFORD NANOPORE TECHNOLOGIES1
PROFILOMIC1
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON1
SECONDA UNIVERSITA DEGLI STUDI DI NAPOLI1
SIENA BIOTECH1
SIGOLIS AB1
STICHTING KATHOLIEKE UNIVERSITEIT1
THE BABRAHAM INSTITUTE1
THE UNIVERSITY OF EDINBURGH1
THE UNIVERSITY OF WESTERN AUSTRALIA1
UNIVERSITA DEGLI STUDI DI FERRARA1
UNIVERSITA DEGLI STUDI DI MILANO1
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA1
UNIVERSITAET DES SAARLANDES1
UNIVERSITAET LEIPZIG1
UNIVERSITAET ULM1
UNIVERSITAETSKLINIKUM ESSEN1
UNIVERSITAETSKLINIKUM FREIBURG1
UNIVERSITE D'AIX MARSEILLE1
UNIVERSITE DE GENEVE1
UNIVERSITY OF COPENHAGEN1
UNIVERSITY OF NEWCASTLE UPON TYNE1
VIB1
VIVIA BIOTECH S L1
WEIZMANN INSTITUTE OF SCIENCE1

Constancy:

Total number of partners: 62
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 62
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2012-10-01Integrated European omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases NEUROMICSparticipant12.000.00019
2011-10-01A BLUEPRINT of Haematopoietic Epigenomes BLUEPRINTparticipant29.996.66445